development at baylor has been working on vaccines for a couple of decades. we started working on coronavirus vaccines ten years ago. and we took this pivot. and all of our vaccines are low cost, protein vaccines that could be made at very low cost. and no limits to the scale that you can produce it at, because it s a technology that is similar to the hepatitis b vaccine. so when i say pivot, our center, which is co-headed by myself and my science partner, mary lynn, we turned around and made a covid vaccine. but then did not get a lot of help, really, from either the federal government. and a lot of international agencies. but countries are so desperate for vaccines, because they knew mrna vaccines weren t coming, as they cannot be scaled. we successfully worked with a company in india, they are